GlassScriptPhysician profile
Jennifer R King
NPI 1689980690
$1,763.88
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $84.46 · 2022: $254 · 2023: $1,330 · 2024: $95.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Food and Beverage: $406 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Food and Beverage | $406.03 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonio | $1,000.00 | 2023 | |
| Medtronic, INC. | $182.80 | 2023 | Mazor X System |
| Pfizer INC. | $154.88 | 2021-2023 | |
| Organon LLC | $149.15 | 2022-2024 | Nexplanon |
| Myovant Sciences INC. | $100.85 | 2021-2022 | |
| Coopersurgical, INC. | $92.01 | 2021-2024 | Paragard T 380a, Paragard T 380a |
| Becton, Dickinson and Company | $28.82 | 2022 | |
| Agile Therapeutics, INC. | $19.35 | 2021 | |
| Exact Sciences Corporation | $18.07 | 2024 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $17.95 | 2023 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.